AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding AIM ImmunoTech Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 43 | 38 | −5 |
| Shares | 7.47M | 6.72M | −747.2K (−10.0%) |
| Value | $6.86M | $7.12M | +$258.9K (+3.8%) |
New holders (2)
Institutions that held AIM ImmunoTech Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 46,678 | $49.0K | 0.00% |
| Cordasco Financial Network | 500 | $1.00K | 0.00% |
Sold out (7)
Institutions that held AIM ImmunoTech Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 48,450 | $45.0K |
| Citadel Advisors LLC | 41,052 | $37.0K |
| Susquehanna International Group, LLP | 37,812 | $35.0K |
| HighTower Advisors, LLC | 24,035 | $22.0K |
| Jane Street Group, LLC | 15,499 | $14.0K |
| Winton Group Ltd | 15,693 | $14.0K |
| FMR LLC | 100 | $0 |